載入...
Peptide vaccines and peptidomimetics targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy
The ErbB family (HER-1, HER-2, HER-3 and HER-4) of receptor tyrosine kinases has been the focus of cancer immunotherapeutic strategies while antiangiogenic therapies have focused on VEGF and its receptors VEGFR-1 and VEGFR-2. Agents targeting receptor tyrosine kinases in oncology include therapeutic...
Na minha lista:
| 發表在: | Future Oncol |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591923/ https://ncbi.nlm.nih.gov/pubmed/22894670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.12.95 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|